trending Market Intelligence /marketintelligence/en/news-insights/trending/vh5Ypd-LnJlMt77l8Q7AfA2 content esgSubNav
In This List

Spark Therapeutics starts common stock offering

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Spark Therapeutics starts common stock offering

Spark Therapeutics Inc. initiated an underwritten public offering of $300 million of its common stock.

The company also intends to grant the underwriters an option to buy up to an additional 15% of the shares offered.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Co. LLC will act as book-running managers for the offering.